CBUS logo

CBUS Cibus, Inc.

NASDAQ · Biotechnology · Healthcare

$1.77
-0.13 (-6.84%)

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-thr…

Market Cap: $135.11Mwww.cibus.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

94
94
Aug 13Aug 13

Quote

Day Range
$1.55 – $1.79
52-Week Range
$1.09 – $4.19
Volume
$331.9K
Market Cap
$135.11M
50-Day Avg
$1.65
200-Day Avg
$1.86
Prev Close
$1.90
Open
$1.73

Valuation & Ratios

P/E Ratio
-0.63
EPS
$-0.28
P/B Ratio
36.47
P/S Ratio
218.79
Debt/Equity
12.28
Current Ratio
0.72
Dividend Yield
+0.0%
Gross Margin
-62.8%

Returns & Efficiency

Return on Equity
-582.2%
Return on Assets
-41.7%
FCF Yield
-6.4%
EV/EBITDA
-11.61

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$3.64M$-127.08M$-2.78
2024$4.26M$-251.39M$-10.83
2023$1.82M$-267.63M$-25.95
2022$157.0K$-16.89M$-0.03
2021$25.99M$-29.20M$-0.05

Social Signal Score

46
5d
46
4 mentions
30d
46
4 mentions
60d
46
4 mentions
90d
46
4 mentions
news: 4

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $-0.24 per share

3of 7 quarters beat consensus

Typical surprise -5.7% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$-0.29 vs $-0.19miss
  • Thu, May 14$-0.33 vs $-0.35beat
  • Tue, Mar 17$-0.42 vs $-0.43beat
  • Thu, Nov 13$-0.44 vs $-0.41miss
  • Thu, Aug 14$-0.61 vs $-0.69beat
  • Thu, May 8$-0.74 vs $-0.70miss

Estimates and results for CBUS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CBUShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (4)

  • Newsseekingalpha.com·1d ago·Positive

    Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newszacks.com·1d ago·Negative

    Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.

    View source ↗
  • Newsmarketbeat.com·1d ago·Negative

    Cibus Q2 Earnings Call Highlights Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America.

    View source ↗
  • Newsglobenewswire.com·1d ago·Neutral

    …NA as conventionally bred Quarterly net cash usage declined 19% sequentially and 31% year over year SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced its financial results for the quarter ended June 30, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.

    View source ↗